RE: Three anti-inflammatory drugs for COVID-19 patients to be studied in WHO-led trial14 Aug 2021 03:14
Thank you Stoney for your reply, very much appreciated.
For me this science and I most readily admit... is way, way over my head, and one that is non conversant like myself can only really deal in ones own very basic research, hence my question.
For me there will always be a potential competitor lurking in the shadows, and the real test is who will get a successful CTS drug onto the market before others do?.
I also agree with you, in that the market is more than large enough for many players etc, for now at least.
I do think that given the potential rewards on offer, time is of the essence, and that is perhaps why HNWI's are taking an interest now because they are more in the know than perhaps you and me?
Time will tell, just my thoughts.
Lets hope GSK have their eyes on SAR?